NCT00637286View on ClinicalTrials.gov

ZAP, US. Zomig for Appropriate for Primary Care

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

May 31, 2005

Conditions

Migraine

Interventions

DRUG

Zolmitriptan

5mg Nasal Spray

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY